“Rare” diseases are something of a misnomer: about 30 million Americans, half of them children, have a rare disease – and 90% have no approved treatments at all. The need…
At the recent CNS Summit – an annual gathering of R&D life science leaders that has taken place since 2009 – Koneksa was proud to sit down with some of…
Using data from digital health technologies is making it possible to measure the performance of investigational treatments more rapidly, completely, and accurately than ever before. What’s a digital biomarker?Biomarkers are,…
This recent conference in Zürich, sponsored by the Foundation for the National Institutes of Health (FNIH), the Wellcome Trust (UK) and the Swiss Federal Institute of Technology in Zürich (ETH…